PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+6.43%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.74B
AUM Growth
+$95.7M
(+3.6%)
Cap. Flow
+$27.5M
Cap. Flow
% of AUM
1%
Top 10 Holdings %
Top 10 Hldgs %
40.58%
Holding
1,201
New
69
Increased
381
Reduced
653
Closed
98
Top Buys
| 1 |
Amazon
AMZN
|
$12.9M |
| 2 |
Palantir
PLTR
|
$12.2M |
| 3 |
Apple
AAPL
|
$11.9M |
| 4 |
Microsoft
MSFT
|
$10.9M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$7.35M |
Top Sells
| 1 |
Broadcom
AVGO
|
$21.5M |
| 2 |
Meta Platforms (Facebook)
META
|
$9.51M |
| 3 |
Tesla
TSLA
|
$3.64M |
| 4 |
Exxon Mobil
XOM
|
$2.05M |
| 5 |
Chevron
CVX
|
$1.77M |
Sector Composition
| 1 | Technology | 44.82% |
| 2 | Consumer Discretionary | 12.21% |
| 3 | Communication Services | 10.56% |
| 4 | Healthcare | 9.71% |
| 5 | Financials | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Old Dominion Freight Line
ODFL
$31.7B
| $3.2M | 0.12% |
18,134
+1,636
| +10% | +$289K |
|
127
GE HealthCare
GEHC
$34.6B
| $3.18M | 0.12% |
40,706
+2,730
| +7% | +$213K |
|
128
Kraft Heinz
KHC
$32.3B
| $3.13M | 0.11% |
102,036
+7,302
| +8% | +$224K |
|
129
Idexx Laboratories
IDXX
$51.4B
| $3.02M | 0.11% |
7,296
+487
| +7% | +$201K |
|
130
Sempra
SRE
$52.9B
| $3M | 0.11% |
34,214
-3,982
| -10% | -$349K |
|
131
Neurocrine Biosciences
NBIX
$14.3B
| $2.97M | 0.11% |
21,723
-7,385
| -25% | -$1.01M |
|
132
HDFC Bank
HDB
$361B
| $2.84M | 0.1% |
44,539
-147
| -0.3% | -$9.39K |
|
133
JD.com
JD
$44.6B
| $2.83M | 0.1% |
81,518
-10,970
| -12% | -$380K |
|
134
Thermo Fisher Scientific
TMO
$186B
| $2.8M | 0.1% |
5,385
-748
| -12% | -$389K |
|
135
United Therapeutics
UTHR
$18.1B
| $2.79M | 0.1% |
7,908
-2,734
| -26% | -$965K |
|
136
Verizon
VZ
$187B
| $2.78M | 0.1% |
69,598
+15,098
| +28% | +$604K |
|
137
Abbott
ABT
$231B
| $2.76M | 0.1% |
24,414
-4,410
| -15% | -$499K |
|
|
ANSS
138
DELISTED
Ansys
ANSS
| $2.75M | 0.1% |
8,166
+440
| +6% | +$148K |
|
139
BioMarin Pharmaceuticals
BMRN
$11.1B
| $2.74M | 0.1% |
41,706
-1,216
| -3% | -$79.9K |
|
140
DexCom
DXCM
$31.6B
| $2.73M | 0.1% |
35,041
+1,922
| +6% | +$149K |
|
141
Williams Companies
WMB
$69.9B
| $2.68M | 0.1% |
49,591
-12,039
| -20% | -$652K |
|
142
Sarepta Therapeutics
SRPT
$1.96B
| $2.68M | 0.1% |
22,017
-6,358
| -22% | -$773K |
|
143
Coca-Cola Europacific Partners
CCEP
$40.4B
| $2.65M | 0.1% |
34,539
+3,814
| +12% | +$293K |
|
144
CoStar Group
CSGP
$37.9B
| $2.65M | 0.1% |
37,053
-1,616
| -4% | -$116K |
|
145
Agnico Eagle Mines
AEM
$76.3B
| $2.62M | 0.1% |
33,482
-3,959
| -11% | -$310K |
|
146
AT&T
T
$212B
| $2.61M | 0.1% |
114,838
+22,640
| +25% | +$516K |
|
147
EOG Resources
EOG
$64.4B
| $2.61M | 0.1% |
21,314
-3,502
| -14% | -$429K |
|
148
Schlumberger
SLB
$53.4B
| $2.61M | 0.1% |
67,957
-14,715
| -18% | -$564K |
|
149
Vistra
VST
$63.7B
| $2.6M | 0.1% |
18,866
-1,396
| -7% | -$192K |
|
150
Moderna
MRNA
$9.78B
| $2.59M | 0.09% |
62,248
-15,979
| -20% | -$664K |
|